6 news items
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
MRVI
13 May 24
barriers to RNA innovation and discovery
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
MRVI
18 Apr 24
at warp speed, to empowering innovative treatments in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
MRVI
10 Apr 24
) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
BREA
CELZ
DIS
8 Mar 24
. This innovative cell-based program is designed to manage abnormal glucose tolerance and preempt the onset of T1D in high-risk individuals. Notably
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
MRVI
22 Feb 24
) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results
5q8coy
MRVI
21 Feb 24
continues to prove its value as a breakthrough modality for innovative medicines," explained Drew Burch, President of Nucleic Acid Production at TriLink
- Prev
- 1
- Next